Literature DB >> 36110702

Propofol's Efficacy and Outcomes on Anxious Children's Behavior in the Course of Dental Therapy: An Interventional Trial.

Swati Singh1, Nudrat Neyaz2, Aditi S Tanwar3, Anand N Patil4, Asim M Khan5, Ateet Kakti6.   

Abstract

Introduction: Tranquility therapies have recently been more popular as a means of reducing anxiety amongst children in the course of painful diagnostic and therapeutic procedures. As a result, a variety of techniques (oral tranquility, intravenous (IV) tranquility) have been developed to assist practitioners in order to deal with such instances. The goal of this trial was to see how effective propofol could be in calming anxious youngsters during the course of dental therapy. The interventional investigation was undertaken at the Hazaribag College of Dental Sciences and Hospital in Jharkhand. Materials and
Methods: To assess the outcomes of intravenous propofol on their performance in the course of therapy, 40 children within the age group of 3-6 years pursuing good physical health but uncooperative in nature (negative or definitely negative, bestowing to Frankel's performance scale) were comprised in the study. The performance rating scale was utilized to assess their performance throughout the therapy (BRS). In addition, the point of tranquility was assessed beforehand. Mann-Whitney U test was utilized to equate male and female points of performance along with gradations of drowsiness. The P value for significance was fixed at 0.05.
Results: All participants' performance and point of tranquility in the course of therapy were promising, and therapy was accomplished for everyone. Mann-Whitney U test revealed no statistically significant differences in point of performance, or gradation of drowsiness amid males and females. Pearson's correlation coefficient revealed a strong positive association of therapy time with awakening time.
Conclusion: Intravenous propofol deep tranquility in the presence of an anesthesiologist was found to be beneficial in restraining nervous and recalcitrant youngsters in the course of dental therapy. Copyright:
© 2022 Journal of Pharmacy and Bioallied Sciences.

Entities:  

Keywords:  Anxiety; ketamine; performance rating scale; propofol

Year:  2022        PMID: 36110702      PMCID: PMC9469281          DOI: 10.4103/jpbs.jpbs_155_22

Source DB:  PubMed          Journal:  J Pharm Bioallied Sci        ISSN: 0975-7406


INTRODUCTION

Due to the high point of anxiety experienced by a large number of children, dental anxiety is one of the highly commonly confronted disorders in dentistry, posing a significant challenge for dentists. Not only do children avoid dental therapy, but they also avoid examinations. Because of this avoidant performance towards dental therapy, dental problems worsen, necessitating more sophisticated and difficult procedures, leading to a rise in anxiety in youngsters.[1] There has been a perceptible upsurge in diagnostic procedures besides trifling surgeries in pediatric patients outside of the traditional operating room in recent decades, as well as increased cognizance of along with attention on tranquility besides pain reduction, consequential in an amplified prerequisite for tranquility systems in dental clinics, emergency sectors, besides radiography services.[23] The outcomes of tranquility on children along with adults are different. In youngsters, the primary aim is to change behavior while also removing anxiety. The child's capacity to restrain their performance besides to comply by means of the dental practitioner is determined by their chronological age along with point of cognitive and emotional development.[4] Distraction techniques, topical or local anesthetic, and minor tranquility are utilized to perform several uncomplicated procedures. In children under the age of six, longer operations that entail the child to be tranquil or youngsters utilizing cognitive impairments, deeper tranquility stages are frequently required to manage their performance.[56] Deep tranquility is beneficial in dentistry for the reason that it allows patients to accomplish therapy, utilizing least volume of psychological along with physiological discomfort possible. Deep tranquility has been utilized in child dentistry for several years.[7] Deep tranquility's superiority over general anesthesia is supported by its advantages, which include a shorter recovery time, less patient preparation, and less monitoring equipment and skill.[7] Chloral hydrate,[8] meperidine,[9] hydroxyzine,[10] promethazine,[11] ketamine,[12] propofol,[13] and midazolam[14] have all been utilized as sedative agents in the dental therapy of pediatric patients, and each has its own set of benefits along with drawbacks. Propofol is the most commonly utilized medicine in intravenous tranquility. A receptor is one of the mechanisms of action on the central nervous system.[13] Propofol influences the amount of neurotransmitter receptors, particularly the gamma-aminobutyric acid. Propofol's high lipophilicity safeguards a swift commencement of action, in addition to swift restructuring from the central to the peripheral compartment producing swift counterpoise of anesthetic activity.[14] There might be a possibility of burning sensation after intravenous administration, as well as the expense of the medicine along with an infusion pump are also downsides.[15] As a result, the goal of this trial was to investigate the efficacy of propofol and its outcomes on anxious children's performance in the course of dental therapy.

MATERIALS AND METHODS

The Department of Paediatric & Preventive Dentistry at Hazaribag College of Dental Sciences and Hospital in Jharkhand undertook an interventional clinical single-arm experiment. The trial involved 40 healthy children of both sexes as per the American Society of Anesthesiologists I (ASA I). Criteria for inclusion included the following: The trial comprised of children aged three to six years (ASA grade I) who needed dental therapy (pulpotomy) in at least two carious primary molars under heavy intravenous tranquility due to their recalcitrant performance (negative or definitely negative on Frankel's performance scale). The youngsters who had never had any previous dental care were included in the trial. Children with allergies to the drugs utilized in the trial as well as those with respiratory tract infections or systemic disorders were excluded. Every child was clinically evaluated by a pediatric dentist, and the parents completed medical questionnaires with the dentist's assistance. Before therapy, all children were told to fast for six hours (from solid foods and non-human milk), four hours (from human milk), and two hours (from water and clear liquids).[4] Prior the process, age, sex, weight, therapy length, recovery period, in addition to vital signs were recorded and monitored every five minutes until the process was completed. Subsequent to the commencement outcomes of tranquility began to appear, an intramuscular route was recognized, and atropine (0.01 mg/kg) was administered by a skilled anesthetist employing midazolam (0.1 mg/kg) with ketamine (0.3 mg/kg). Intravenous tranquility was sustained by administering propofol (10–20 mg) intermittently (bolus injection) built on the anaesthesiologist's validation to keep the kid in a deep sedated state. The performance rating scale (BARS) was utilized to record the child's performance, and a pre-validated tranquility scale was utilized to record the tranquility points in the course of the therapy. Any difficulties were noted at the conclusion of therapy, and the children were released following complete recovery besides normal vital signs. Parents were contacted 24 hours later in order to confirm if there had been any issues or not.

Statistical examination

The Statistical Package for the Social Sciences (SPSS, version 23.0, IBM, USA) was utilized for statistical analysis after data collection. In the course of the therapy, the Mann–Whitney U test was employed to investigate the variations in points of performance and gradations of drowsiness in male and female patients. The association of therapy time with recovery duration was investigated utilizing Pearson's correlation coefficient. The P value for significance was fixed at 0.05.

RESULTS

A total of 40 children of mean age of 8.9 ± 2.4 years, participated in the trial [Table 1]. The sample comprised of 30 males and 10 females. As indicated in Table 2, the majority of vital values were within normal ranges for healthy pediatric patients. The findings of pair-wise Mann–Whitney assessments amid males and females in terms of point of performance and gradation of drowsiness during therapy was an average of 48.3 ± 14.5 minutes, while recovery was an average of 28.6 ± 5.6 minutes. Amid them, Pearson's correlation coefficient was 0.712, which deemed a strong connection (P = 0.01).
Table 1

Demographic details

VariableValue
Sex (Male:Female)30:10
Age (years) (mean±SD)8.9±2.4
Weight (kg) (mean±SD)24.2±6.3
Therapy duration (minutes) (mean±SD)48.3±14.5
Recovery time (minutes) (mean±SD)28.6±5.6
Table 2

Vital Signs

Vital signsOverall (Mean±SD)Male (Mean±SD)Female (Mean±SD)
Systolic blood pressure (mmHg)103.5±4.5105.8±4.5106.2±4.7
Diastolic blood pressure (mmHg)68.1±4.269.4±4.466.3±4.2
Heart rate (beats/min)106.03±8.34111±6.8102.03±7.8
Oxygen saturation (SpO2) (%)99.3±0.898.44±0.799.8±0.4
Respiratory rate (breaths/min)22.6±0.823.6±0.920.9±0.7
Demographic details Vital Signs

DISCUSSION

Propofol is the commonly utilized drug for intravenous tranquility in children because of its well-known benefits, such as rapid onset and recovery. As a result, it is commonly utilized to calm youngsters who are supposed to undergo therapeutic processes or diagnostic therapies. Propofol is considered to have a powerful sedative outcome and in addition, can be regarded as a profound sedative or even a general anesthetic agent.[12345678910] Because of the substantial hazards associated with heavy tranquility in children—for example, airway obstruction, hypoxia, hypoventilation, and apnea—the attendance of an anesthesiologist is suggested.[4] Mild desaturation (85%–90% SpO2) was the most prevalent tranquility consequence found proximately subsequent to delivery of intravenous propofol bolus. Mild desaturation was seen in 13 children (56.5%); in all the cases, normal oxygen saturation was quickly reestablished (> 95%) after neck displacement (head tilt, chin lift) utilizing or avoiding nasal oxygen delivery. There has been no preceding research in the arena of dentistry to govern the outcome of propofol provided in alternating boluses on the performance of children in the course of dental therapy. To our knowledge, this research is thought to be the first of its sort. One of propofol's downsides, that is, the need for an expensive infusion pump, could be mitigated by administering it in this manner.[1112131415] The conventional procedure for deep tranquility or general anesthesia in the course of oral and maxillofacial surgery is the intermittent bolus technique. Many investigations comparing intermittent bolus versus continuous infusion strategies reported no significant differences in adequate tranquility and diagnostic procedure quality.[16] The usage of atropine has critically reduced the risk of respiratory complications, for instance, oxygen desaturation as a result of excessive salivation that is consistent with the findings of supplementary trials, indicating its ability to restrain excessive salivation in the respiratory tract, as well as nausea and vomiting that are considered to be the most frequent complications on inducing tranquility with ketamine. The current trial shows that there is a robust affiliation between therapy duration and recovery time, that is, the longer the therapy duration, the longer the recovery time. As a result, propofol can be valuable when utilized in the course of relatively short dental procedures. It should be noted, however, that there have been no prior trials in the dental field that has looked into this relationship.

CONCLUSION

From the scope of the current research, it can be concluded that the administration of propofol in intermittent boluses is safe and effective in managing apprehensive and recalcitrant children in the course of dental therapy, with shorter recovery times. There was no statistically significant difference in the point of performance or the gradation of tranquility between males and females.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  14 in total

Review 1.  Distraction as a technique to control pain in pediatric patients during venipuncture. A narrative review of literature.

Authors:  Carlo Vetri Buratti; Francesco Angelino; Julita Sansoni; Loredana Fabriani; Lucia Mauro; Roberto Latina
Journal:  Prof Inferm       Date:  2015 Jan-Mar

2.  Clinical guideline on the elective use of minimal, moderate, and deep sedation and general anesthesia for pediatric dental patients.

Authors: 
Journal:  Pediatr Dent       Date:  2004       Impact factor: 1.874

3.  Sedation in uncooperative children undergoing dental procedures: a comparative evaluation of midazolam, propofol and ketamine.

Authors:  Kavitha Rai; Amitha M Hegde; Kukul Goel
Journal:  J Clin Pediatr Dent       Date:  2007       Impact factor: 1.065

4.  A comparison study between ketamine and ketamine-promethazine combination for oral sedation in pediatric dental patients.

Authors:  Tina Bui; Ronald J Redden; Scott Murphy
Journal:  Anesth Prog       Date:  2002

Review 5.  Anxiolytic activity of chloral hydrate and hydroxyzine.

Authors:  M Gladney; R T Stanley; S E Hendricks
Journal:  Pediatr Dent       Date:  1994 May-Jun       Impact factor: 1.874

6.  Diprivan (ICI 35868, 2, 6, di-isoprophylphenol), a new intravenous anesthetic.

Authors:  B C Pecaro; T Houting
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1985-12

7.  Comparison of the sedative effectiveness of two pharmacological regimens.

Authors:  J M Davila; A E Herman; H M Proskin; D Vitale
Journal:  ASDC J Dent Child       Date:  1994 Jul-Aug

8.  Stress Reduction through Audio Distraction in Anxious Pediatric Dental Patients: An Adjunctive Clinical Study.

Authors:  Divya Singh; Firoza Samadi; Jn Jaiswal; Abhay Mani Tripathi
Journal:  Int J Clin Pediatr Dent       Date:  2015-02-09

9.  Acceptability of intravenous propofol sedation for adolescent dental care.

Authors:  C Dixon; A Aspinall; S Rolfe; C Stevens
Journal:  Eur Arch Paediatr Dent       Date:  2019-10-08

10.  Comparison of the Sedation Quality of Etomidate, Propofol, and Midazolam in Combination with Fentanyl During Phacoemulsification Cataract Surgery: A Double-Blind, Randomized, Controlled, Clinical Trial.

Authors:  Leili Adinehmehr; Hamidreza Shetabi; Darioush Moradi Farsani; Ali Salehi; Mohadese Noorbakhsh
Journal:  Anesth Pain Med       Date:  2019-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.